Literature DB >> 7894210

Successful treatment of meningoencephalitis caused by Mycobacterium avium intracellulare in AIDS.

R Malessa1, H C Diener, T Olbricht, B Böhmer, N H Brockmeyer.   

Abstract

A wide variety of pathologies afflicting the CNS is see in patients infected with the human immunodeficiency virus. We report the case of relapsing meningoencephalitis caused by Mycobacterium avium intracellulare (MAI) in a homosexual male with the acquired immunodeficiency syndrome in whom repeated use of polymerase chain reaction was required to detect MAI-specific DNA in the cerebrospinal fluid. Successful responses to early empirical antibiotic combination treatment, including the drugs clarithromycin and rifabutin, were demonstrated by clinical, EEG, and CSF improvement during an 8-month period. To our knowledge, this study presents the first known patient with the acquired immunodeficiency syndrome effectively treated for MAI meningoencephalitis and suggests that modern antimycobacterial combination therapy may improve the poor prognosis of CNS infections with nontuberculous mycobacteria.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7894210     DOI: 10.1007/bf00190739

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  14 in total

Review 1.  Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.

Authors:  C R Horsburgh
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

2.  Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients.

Authors:  J Hoy; A Mijch; M Sandland; L Grayson; R Lucas; B Dwyer
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

3.  Chronic HIV encephalitis.

Authors:  K Felgenhauer; W Lüer; S Poser
Journal:  J Neuroimmunol       Date:  1988-12       Impact factor: 3.478

4.  Molecular diagnostics for infectious diseases: where do we stand?

Authors:  A Telenti
Journal:  Clin Investig       Date:  1994-06

5.  [Neuropathologic study of 135 adult cases of acquired immunodeficiency syndrome (AIDS)].

Authors:  F Gray; C Geny; F Lionnet; E Dournon; G Fenelon; R Gherardi; J Poirier
Journal:  Ann Pathol       Date:  1991       Impact factor: 0.407

6.  Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages.

Authors:  C Perronne; A Gikas; C Truffot-Pernot; J Grosset; J L Vilde; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

7.  Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients.

Authors:  S D Nightingale; L T Byrd; P M Southern; J D Jockusch; S X Cal; B A Wynne
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

8.  Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy.

Authors:  C R Horsburgh; J A Havlik; D A Ellis; E Kennedy; S A Fann; R E Dubois; S E Thompson
Journal:  Am Rev Respir Dis       Date:  1991-09

9.  Molecular epidemiology of tuberculosis in Austria.

Authors:  W Vogetseder; M Fille; S Patscheider; M P Dierich; F Allerberger
Journal:  Clin Investig       Date:  1994-01

Review 10.  The neuropathology of human immunodeficiency virus infection. The Dallas, Texas, experience.

Authors:  D K Burns; R C Risser; C L White
Journal:  Arch Pathol Lab Med       Date:  1991-11       Impact factor: 5.534

View more
  2 in total

Review 1.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

2.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.